India
· Delayed Price · Currency is INR Ajanta Pharma Statistics
Total Valuation
Ajanta Pharma has a market cap or net worth of INR 327.58 billion. The enterprise value is 320.49 billion.
| Market Cap | 327.58B |
| Enterprise Value | 320.49B |
Important Dates
The next estimated earnings date is Friday, May 2, 2025.
| Earnings Date | May 2, 2025 |
| Ex-Dividend Date | Nov 6, 2024 |
Share Statistics
Ajanta Pharma has 124.89 million shares outstanding. The number of shares has decreased by -0.87% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 124.89M |
| Shares Change (YoY) | -0.87% |
| Shares Change (QoQ) | -0.12% |
| Owned by Insiders (%) | 42.33% |
| Owned by Institutions (%) | 19.99% |
| Float | 41.84M |
Valuation Ratios
The trailing PE ratio is 36.65 and the forward PE ratio is 31.52.
| PE Ratio | 36.65 |
| Forward PE | 31.52 |
| PS Ratio | 7.26 |
| PB Ratio | 8.94 |
| P/TBV Ratio | 8.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 35.70 |
| EV / Sales | 7.07 |
| EV / EBITDA | 25.49 |
| EV / EBIT | 28.49 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | n/a |
| Interest Coverage | 69.49 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 19.47% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 5.61M |
| Profits Per Employee | 1.11M |
| Employee Count | 8,073 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.58% in the last 52 weeks. The beta is 0.24, so Ajanta Pharma's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | +18.58% |
| 50-Day Moving Average | 2,656.00 |
| 200-Day Moving Average | 2,827.17 |
| Relative Strength Index (RSI) | 48.72 |
| Average Volume (20 Days) | 163,652 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ajanta Pharma had revenue of INR 45.32 billion and earned 8.98 billion in profits. Earnings per share was 71.57.
| Revenue | 45.32B |
| Gross Profit | 34.26B |
| Operating Income | 11.25B |
| Pretax Income | 11.98B |
| Net Income | 8.98B |
| EBITDA | 12.45B |
| EBIT | 11.25B |
| Earnings Per Share (EPS) | 71.57 |
Balance Sheet
The company has 7.42 billion in cash and 327.90 million in debt, giving a net cash position of 7.09 billion or 56.78 per share.
| Cash & Cash Equivalents | 7.42B |
| Total Debt | 327.90M |
| Net Cash | 7.09B |
| Net Cash Per Share | 56.78 |
| Equity (Book Value) | 36.77B |
| Book Value Per Share | 293.33 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 75.59%, with operating and profit margins of 24.83% and 19.81%.
| Gross Margin | 75.59% |
| Operating Margin | 24.83% |
| Pretax Margin | 26.43% |
| Profit Margin | 19.81% |
| EBITDA Margin | 27.48% |
| EBIT Margin | 24.83% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 56.00, which amounts to a dividend yield of 2.13%.
| Dividend Per Share | 56.00 |
| Dividend Yield | 2.13% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | 0.87% |
| Shareholder Yield | 3.00% |
| Earnings Yield | 2.74% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on June 22, 2022. It was a forward split with a ratio of 1.5.
| Last Split Date | Jun 22, 2022 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |